// App-Quantinova.ai

e14033 : Quantification of activated and exhausted immune cell populations and simultaneous characterization of circulating tumor cells (CTCs) in peripheral blood of cancer patients receiving checkpoint inhibitor therapy.

Researchers

Presenter

  • Gordon Vansant

Principal Investigators

  • Rachel Krupa

  • Robin Richardson

  • Priscilla Ontiveros

  • Jiyun Byun

  • Mark Landers

  • Ryan Dittamore

Medical Centers

  • Epic Sciences, Inc., San Diego, CA

Locations

  • United States

Companies

  • EPIC SCIENCES, INC.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Cluster of Differentiation 4

  • Cluster of differentiation 45

  • Programmed cell death protein 1

  • Programmed death-ligand 1

  • Cluster of differentiation 8A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved